Yoo, J.-J.; Yu, S.J.; Na, J.; Kim, K.; Cho, Y.Y.; Lee, Y.B.; Cho, E.J.; Lee, J.-H.; Kim, Y.J.; Youn, H.;
et al. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. Int. J. Mol. Sci. 2019, 20, 1292.
https://doi.org/10.3390/ijms20061292
AMA Style
Yoo J-J, Yu SJ, Na J, Kim K, Cho YY, Lee YB, Cho EJ, Lee J-H, Kim YJ, Youn H,
et al. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2019; 20(6):1292.
https://doi.org/10.3390/ijms20061292
Chicago/Turabian Style
Yoo, Jeong-Ju, Su Jong Yu, Juri Na, Kyungmin Kim, Young Youn Cho, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Hyewon Youn,
and et al. 2019. "Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma" International Journal of Molecular Sciences 20, no. 6: 1292.
https://doi.org/10.3390/ijms20061292
APA Style
Yoo, J. -J., Yu, S. J., Na, J., Kim, K., Cho, Y. Y., Lee, Y. B., Cho, E. J., Lee, J. -H., Kim, Y. J., Youn, H., & Yoon, J. -H.
(2019). Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. International Journal of Molecular Sciences, 20(6), 1292.
https://doi.org/10.3390/ijms20061292